Information found on this page has been archived and is for reference, research or recordkeeping purposes. Please visit NRC's new site for the most recent information.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
IMRIS is a Canadian manufacturer of magnetic resonance imaging (MRI) systems for use in neurosurgical operating rooms and an example of one of several successful companies that have evolved as a result of the innovative research conducted at the NRC Institute for Biodiagnostics.
In 1997, IMRIS was created to commercialize NRC-IBD’s mobile MRI technology for intraoperative surgical imaging, the only one of its kind in the world. Situated in Winnipeg, Manitoba, the company designs and manufactures surgical imaging systems for use in neurological, spinal and soft tissue procedures.
In the new frontier of MR-guided surgery, IMRIS stands out as a leader. This NRC-IBD spin-off has broken through the international sales barrier, selling several multi-million dollar magnetic resonance imaging (MRI) systems to clients in major American cities. In November 2007, IMRIS closed a $40M initial public offering (IPO) on the TSX, the highest medical device IPO in TSX history.
IMRIS employs more than 100 highly qualified individuals in Winnipeg. It currently has installations in hospitals in Calgary, Boston, Wilkes-Barre and several other cities.